Greenlight Biosciences Hldgs Pbc (GRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -1 |
| Other Working Capital | 1 |
| Operating Cash Flow | $0 |
| Cash Flows From Investing Activities | |
| Investing Cash Flow | $N/A |
| Cash Flows From Financing Activities | |
| Change In Short Term Borrowing | 28 |
| Common Stock Issued | 25 |
| Other Financing Activity | -28 |
| Financing Cash Flow | $25 |
| End Cash Position | 25 |
| Net Cash Flow | $25 |
| Free Cash Flow | |